You are about to leave the CoverOne website and are being redirected to a non-CoverOne website. Neither EMD Serono nor Pfizer review or control the content of the following website. This redirection does not constitute an endorsement by EMD Serono or Pfizer of the following organization or any information provided by the organization.

Click Here For PAYER COVERAGE MAP

COVERAGE AND CODING RESOURCES

Coverage, coding, and billing requirements for BAVENCIO® (avelumab) Injection 20mg/mL may vary by payer, plan, setting of care, and patient.
Please download billing and coding resources for BAVENCIO by clicking below:

BAVENCIO Coverage, Coding, and Payment Guide
ⓘ
Download Full Prescribtion Information
BAVENCIO Coding Sheet
ⓘ
Download Full Prescribtion Information
Sample CMS-1500 Claim Form for BAVENCIO for Physician
Sample UB-04 Claim Form for BAVENCIO for Outpatient Hospital
 
 
 

Please call CoverOne if you have specific reimbursement questions about a patient, or fax a completed CoverOne Enrollment Form to 1-800-214-7295 or enroll online to request patient-specific services.

When BAVENCIO is used in combination with axitinib, questions related to reimbursement and access for axitinib may be referred to Pfizer Oncology TogetherTM.
Pfizer Oncology TogetherTM provides personalized support and financial assistance resources to help patients access their prescribed axitinib. To learn more, call 1-877-744-5675 (Monday–Friday 8 AM–8 PM ET) or visit Pfizer Oncology Together.

EMD Serono, Inc and Pfizer Inc do not guarantee coverage and/or reimbursement for  BAVENCIO. Coverage, coding, and reimbursement policies vary significantly by payer, patient, and setting of care. Actual coverage and reimbursement decisions are made by individual payers following the receipt of claims. Patients and healthcare professionals should always verify coverage, coding, and reimbursement guidelines on a payer and patient -specific basis.

TERMS OF USE     PRIVACY POLICY     CONTACT US     SITE MAP     COOKIES SETTINGS

US-AVE-00860     January 2022
©2021 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved. EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada. BAVENCIO is a registered trademark of Merck KGaA, Darmstadt, Germany or its affiliates.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.